Übersichtsarbeit
Antifibrogenic Therapies in Chronic HCV Infection
Current Drug Target -Infectious Disorders · 2001
DOI: 10.2174/1568005014606053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -Infectious Disorders, 2001. Verfasst von I Shimizu. Beteiligte Einrichtung: Second Department of Internal Medicine, Tokushima University School of Medicine, Tokushima, Japan. shimizui@clin.med.tokushima-u.ac.jp. Die Arbeit wurde bisher 30-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AntioxidantsHepatitis C, ChronicHepatocyte Growth FactorHepatocytesHumansInterferonsLiver CirrhosisOligopeptidesRetinoidsT-Lymphocytes, CytotoxicTransforming Growth Factor beta
Substanzen
AntioxidantsOligopeptidesRetinoidsTransforming Growth Factor betaHepatocyte Growth Factorarginyl-glycyl-aspartic acidInterferons
Autor:innen und Institutionen
- Second Department of Internal Medicine, Tokushima University School of Medicine, Tokushima, Japan. shimizui@clin.med.tokushima-u.ac.jp
Zitieren
APA
Shimizu, I. (2001). Antifibrogenic Therapies in Chronic HCV Infection. Current Drug Target -Infectious Disorders. https://doi.org/10.2174/1568005014606053
Vancouver
Shimizu I. Antifibrogenic Therapies in Chronic HCV Infection. Current Drug Target -Infectious Disorders. 2001. doi:10.2174/1568005014606053
BibTeX
@article{Shimizu2001,
author = {Shimizu, I},
title = {Antifibrogenic Therapies in Chronic HCV Infection},
journal = {Current Drug Target -Infectious Disorders},
year = {2001},
doi = {10.2174/1568005014606053}
}
EUVIMED